Antisense oligonucleotide - Creyon Bio
Latest Information Update: 22 May 2024
At a glance
- Originator Creyon Bio
- Class Antisense oligonucleotides
- Mechanism of Action Gene silencing
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Clinical Phase Unknown Neurological disorders